Oral Anticoagulants vs Aspirin in Nonvalvular Atrial Fibrillation
Carl van Walraven(University of Ottawa), B S P Hellemons, Daniel E. Singer(Massachusetts General Hospital), Andreas Laupacis, Yuchiao Chang(Harvard University), Peter J. Koudstaal(Apple (Israel)), Robert G. Hart(University of British Columbia), Stuart Connolly, Palle Petersen
Cited by 721
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Prevalence of Diagnosed Atrial Fibrillation in Adults
|JAMA|2001|6.2k
Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population
|The American Journal of Cardiology|2013|1.3k
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
|New England Journal of Medicine|2003|1.3k
Canadian atrial fibrillation anticoaguiation (CAFA) study
|Journal of the American College of Cardiology|1991|1.1k